Global Human Rotavirus Vaccine Market Insights and Forecast to 2026

    • ID: AR2947228
    • 30 July, 2020
    • Other
    • Region: Global
    • 112 Pages
    • QYResearch

    1 Study Coverage

    • 1.1 Human Rotavirus Vaccine Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Human Rotavirus Vaccine Manufacturers Covered: Ranking by Revenue
    • 1.4 Market by Type
      • 1.4.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Type
      • 1.4.2 Rotarix
      • 1.4.3 RotaTeq
      • 1.4.4 Rotavac
      • 1.4.5 Rotavin-M1
      • 1.4.6 Lanzhou lamb
      • 1.4.7 Others
    • 1.5 Market by Application
      • 1.5.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Application
      • 1.5.2 Hospitals & Clinics
      • 1.5.3 Academic And Research
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Human Rotavirus Vaccine Market Size, Estimates and Forecasts
      • 2.1.1 Global Human Rotavirus Vaccine Revenue 2015-2026
      • 2.1.2 Global Human Rotavirus Vaccine Sales 2015-2026
    • 2.2 Global Human Rotavirus Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
      • 2.2.1 Global Human Rotavirus Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
      • 2.2.2 Global Human Rotavirus Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

    3 Global Human Rotavirus Vaccine Competitor Landscape by Players

    • 3.1 Human Rotavirus Vaccine Sales by Manufacturers
      • 3.1.1 Human Rotavirus Vaccine Sales by Manufacturers (2015-2020)
      • 3.1.2 Human Rotavirus Vaccine Sales Market Share by Manufacturers (2015-2020)
    • 3.2 Human Rotavirus Vaccine Revenue by Manufacturers
      • 3.2.1 Human Rotavirus Vaccine Revenue by Manufacturers (2015-2020)
      • 3.2.2 Human Rotavirus Vaccine Revenue Share by Manufacturers (2015-2020)
      • 3.2.3 Global Human Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
      • 3.2.4 Global Top 10 and Top 5 Companies by Human Rotavirus Vaccine Revenue in 2019
      • 3.2.5 Global Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.3 Human Rotavirus Vaccine Price by Manufacturers
    • 3.4 Human Rotavirus Vaccine Manufacturing Base Distribution, Product Types
      • 3.4.1 Human Rotavirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Human Rotavirus Vaccine Product Type
      • 3.4.3 Date of International Manufacturers Enter into Human Rotavirus Vaccine Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type (2015-2026)

    • 4.1 Global Human Rotavirus Vaccine Market Size by Type (2015-2020)
      • 4.1.1 Global Human Rotavirus Vaccine Sales by Type (2015-2020)
      • 4.1.2 Global Human Rotavirus Vaccine Revenue by Type (2015-2020)
      • 4.1.3 Human Rotavirus Vaccine Average Selling Price (ASP) by Type (2015-2026)
    • 4.2 Global Human Rotavirus Vaccine Market Size Forecast by Type (2021-2026)
      • 4.2.1 Global Human Rotavirus Vaccine Sales Forecast by Type (2021-2026)
      • 4.2.2 Global Human Rotavirus Vaccine Revenue Forecast by Type (2021-2026)
      • 4.2.3 Human Rotavirus Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
    • 4.3 Global Human Rotavirus Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Market Size by Application (2015-2026)

    • 5.1 Global Human Rotavirus Vaccine Market Size by Application (2015-2020)
      • 5.1.1 Global Human Rotavirus Vaccine Sales by Application (2015-2020)
      • 5.1.2 Global Human Rotavirus Vaccine Revenue by Application (2015-2020)
      • 5.1.3 Human Rotavirus Vaccine Price by Application (2015-2020)
    • 5.2 Human Rotavirus Vaccine Market Size Forecast by Application (2021-2026)
      • 5.2.1 Global Human Rotavirus Vaccine Sales Forecast by Application (2021-2026)
      • 5.2.2 Global Human Rotavirus Vaccine Revenue Forecast by Application (2021-2026)
      • 5.2.3 Global Human Rotavirus Vaccine Price Forecast by Application (2021-2026)

    6 North America

    • 6.1 North America Human Rotavirus Vaccine by Country
      • 6.1.1 North America Human Rotavirus Vaccine Sales by Country
      • 6.1.2 North America Human Rotavirus Vaccine Revenue by Country
      • 6.1.3 U.S.
      • 6.1.4 Canada
    • 6.2 North America Human Rotavirus Vaccine Market Facts & Figures by Type
    • 6.3 North America Human Rotavirus Vaccine Market Facts & Figures by Application

    7 Europe

    • 7.1 Europe Human Rotavirus Vaccine by Country
      • 7.1.1 Europe Human Rotavirus Vaccine Sales by Country
      • 7.1.2 Europe Human Rotavirus Vaccine Revenue by Country
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 U.K.
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Human Rotavirus Vaccine Market Facts & Figures by Type
    • 7.3 Europe Human Rotavirus Vaccine Market Facts & Figures by Application

    8 Asia Pacific

    • 8.1 Asia Pacific Human Rotavirus Vaccine by Region
      • 8.1.1 Asia Pacific Human Rotavirus Vaccine Sales by Region
      • 8.1.2 Asia Pacific Human Rotavirus Vaccine Revenue by Region
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 South Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Taiwan
      • 8.1.9 Indonesia
      • 8.1.10 Thailand
      • 8.1.11 Malaysia
      • 8.1.12 Philippines
      • 8.1.13 Vietnam
    • 8.2 Asia Pacific Human Rotavirus Vaccine Market Facts & Figures by Type
    • 8.3 Asia Pacific Human Rotavirus Vaccine Market Facts & Figures by Application

    9 Latin America

    • 9.1 Latin America Human Rotavirus Vaccine by Country
      • 9.1.1 Latin America Human Rotavirus Vaccine Sales by Country
      • 9.1.2 Latin America Human Rotavirus Vaccine Revenue by Country
      • 9.1.3 Mexico
      • 9.1.4 Brazil
      • 9.1.5 Argentina
    • 9.2 Central & South America Human Rotavirus Vaccine Market Facts & Figures by Type
    • 9.3 Central & South America Human Rotavirus Vaccine Market Facts & Figures by Application

    10 Middle East and Africa

    • 10.1 Middle East and Africa Human Rotavirus Vaccine by Country
      • 10.1.1 Middle East and Africa Human Rotavirus Vaccine Sales by Country
      • 10.1.2 Middle East and Africa Human Rotavirus Vaccine Revenue by Country
      • 10.1.3 Turkey
      • 10.1.4 Saudi Arabia
      • 10.1.5 U.A.E
    • 10.2 Middle East and Africa Human Rotavirus Vaccine Market Facts & Figures by Type
    • 10.3 Middle East and Africa Human Rotavirus Vaccine Market Facts & Figures by Application

    11 Company Profiles

    • 11.1 Bharat Biotech
      • 11.1.1 Bharat Biotech Corporation Information
      • 11.1.2 Bharat Biotech Description and Business Overview
      • 11.1.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
      • 11.1.4 Bharat Biotech Human Rotavirus Vaccine Products Offered
      • 11.1.5 Bharat Biotech Related Developments
    • 11.2 Merck
      • 11.2.1 Merck Corporation Information
      • 11.2.2 Merck Description and Business Overview
      • 11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
      • 11.2.4 Merck Human Rotavirus Vaccine Products Offered
      • 11.2.5 Merck Related Developments
    • 11.3 GlaxoSmithKline
      • 11.3.1 GlaxoSmithKline Corporation Information
      • 11.3.2 GlaxoSmithKline Description and Business Overview
      • 11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
      • 11.3.4 GlaxoSmithKline Human Rotavirus Vaccine Products Offered
      • 11.3.5 GlaxoSmithKline Related Developments
    • 11.1 Bharat Biotech
      • 11.1.1 Bharat Biotech Corporation Information
      • 11.1.2 Bharat Biotech Description and Business Overview
      • 11.1.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
      • 11.1.4 Bharat Biotech Human Rotavirus Vaccine Products Offered
      • 11.1.5 Bharat Biotech Related Developments

    12 Future Forecast by Regions (Countries) (2021-2026)

    • 12.1 Human Rotavirus Vaccine Market Estimates and Projections by Region
      • 12.1.1 Global Human Rotavirus Vaccine Sales Forecast by Regions 2021-2026
      • 12.1.2 Global Human Rotavirus Vaccine Revenue Forecast by Regions 2021-2026
    • 12.2 North America Human Rotavirus Vaccine Market Size Forecast (2021-2026)
      • 12.2.1 North America: Human Rotavirus Vaccine Sales Forecast (2021-2026)
      • 12.2.2 North America: Human Rotavirus Vaccine Revenue Forecast (2021-2026)
      • 12.2.3 North America: Human Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
    • 12.3 Europe Human Rotavirus Vaccine Market Size Forecast (2021-2026)
      • 12.3.1 Europe: Human Rotavirus Vaccine Sales Forecast (2021-2026)
      • 12.3.2 Europe: Human Rotavirus Vaccine Revenue Forecast (2021-2026)
      • 12.3.3 Europe: Human Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
    • 12.4 Asia Pacific Human Rotavirus Vaccine Market Size Forecast (2021-2026)
      • 12.4.1 Asia Pacific: Human Rotavirus Vaccine Sales Forecast (2021-2026)
      • 12.4.2 Asia Pacific: Human Rotavirus Vaccine Revenue Forecast (2021-2026)
      • 12.4.3 Asia Pacific: Human Rotavirus Vaccine Market Size Forecast by Region (2021-2026)
    • 12.5 Latin America Human Rotavirus Vaccine Market Size Forecast (2021-2026)
      • 12.5.1 Latin America: Human Rotavirus Vaccine Sales Forecast (2021-2026)
      • 12.5.2 Latin America: Human Rotavirus Vaccine Revenue Forecast (2021-2026)
      • 12.5.3 Latin America: Human Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
    • 12.6 Middle East and Africa Human Rotavirus Vaccine Market Size Forecast (2021-2026)
      • 12.6.1 Middle East and Africa: Human Rotavirus Vaccine Sales Forecast (2021-2026)
      • 12.6.2 Middle East and Africa: Human Rotavirus Vaccine Revenue Forecast (2021-2026)
      • 12.6.3 Middle East and Africa: Human Rotavirus Vaccine Market Size Forecast by Country (2021-2026)

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Porter's Five Forces Analysis
    • 13.5 Primary Interviews with Key Human Rotavirus Vaccine Players (Opinion Leaders)

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Human Rotavirus Vaccine Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Human Rotavirus Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Rotavirus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

      Segment by Type, the Human Rotavirus Vaccine market is segmented into
      Rotarix
      RotaTeq
      Rotavac
      Rotavin-M1
      Lanzhou lamb
      Others

      Segment by Application, the Human Rotavirus Vaccine market is segmented into
      Hospitals & Clinics
      Academic And Research
      Others

      Regional and Country-level Analysis
      The Human Rotavirus Vaccine market is analysed and market size information is provided by regions (countries).
      The key regions covered in the Human Rotavirus Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
      The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
      Competitive Landscape and Human Rotavirus Vaccine Market Share Analysis
      Human Rotavirus Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Rotavirus Vaccine business, the date to enter into the Human Rotavirus Vaccine market, Human Rotavirus Vaccine product introduction, recent developments, etc.

      The major vendors covered:
      Bharat Biotech
      Merck
      GlaxoSmithKline
      ...



      Summary:
      Human Rotavirus Vaccine Market Research Report is about Human Rotavirus Vaccine Industry study. Get complete Human Rotavirus Vaccine market research report published after Market Study, Industrial Analysis with Trends & Statistics. Human Rotavirus Vaccine Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED

      $3,900.00
      $3,900.00
      $3,900.00
      $3,900.00
      $3,900.00